AVEANNA HEALTHCARE Reports Q2 Earnings for FY 2023 on August 10

August 18, 2023

🌥️Earnings Overview

On August 10 2023, AVEANNA HEALTHCARE ($NASDAQ:AVAH) reported their earnings results for the fiscal year ending June 30 2023. Total revenue for Q2 of the year totaled USD 471.9 million, a 6.5% increase from the same quarter of the previous year. Net income was also up, reaching USD 25.6 million, or a 105.4% increase from the same time last year.

Stock Price

On Thursday, AVEANNA HEALTHCARE announced its Q2 earnings for the fiscal year 2023. The stock opened at $1.7 and closed at $1.8, which represents a 3.4% increase from the previous closing price of $1.8. This marked the third consecutive quarter of increased revenue for AVEANNA, demonstrating the growing success of the healthcare provider. This increase in revenue is attributed to the company’s focus on providing the highest quality of care to their patients.

In addition, AVEANNA has implemented cost-cutting initiatives to reduce expenses and improved operational efficiency. This has enabled them to maximize their profits and maintain healthy margins. The company’s CEO, Brian Huffman, expressed his pleasure with AVEANNA’s performance in the quarter and said that they are continuing to focus on providing exceptional care to their patients. He also mentioned that they have plans for expansion in the near future which will help further their growth and success. These results show that AVEANNA is continuing to be a leader in the healthcare industry due to their commitment to providing high-quality care. Their financial performance in Q2 reinforces their position as a reliable healthcare provider and we can expect even more success for the company in the future. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Aveanna Healthcare. More…

    Total Revenues Net Income Net Margin
    1.83k -219.88 -4.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Aveanna Healthcare. More…

    Operations Investing Financing
    -22.07 -12.93 45.55
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Aveanna Healthcare. More…

    Total Assets Total Liabilities Book Value Per Share
    1.74k 1.75k -0.02
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Aveanna Healthcare are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    8.9% -18.7% -5.1%
    FCF Margin ROE ROA
    -1.7% 305.7% -3.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we’ve conducted an in-depth analysis of AVEANNA HEALTHCARE‘s financial and business wellbeing. After careful consideration, we have rated AVEANNA HEALTHCARE as a high risk investment. Through our detailed analysis, we detected four risk warnings within the company‚Äôs income sheet, balance sheet, cashflow statement and financial journal. To view the complete analysis, all you need to do is become a registered user of GoodWhale. Our user friendly platform allows you to keep up to date on the latest industry trends and make informed decisions about your investments. Sign up today and get the most out of AVEANNA HEALTHCARE and any other investments you may have. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The competitive landscape in the home healthcare services industry is heating up, with Aveanna Healthcare Holdings Inc taking on Amedisys Inc, InnovAge Holding Corp, and National Healthcare Corp. All four companies are vying for a piece of the pie in an industry that is expected to grow significantly in the coming years. While each company has its own strengths and weaknesses, it is clear that Aveanna is in a strong position to compete against its rivals.

    – Amedisys Inc ($NASDAQ:AMED)

    Amedisys Inc is a home health care company with a market cap of 3.17B as of 2022. The company has a Return on Equity of 11.56%. Amedisys Inc provides home health and hospice services to patients in the United States. The company offers a variety of services, including skilled nursing, physical therapy, occupational therapy, speech therapy, and home health aides. Amedisys Inc also provides palliative care and hospice services.

    – InnovAge Holding Corp ($NASDAQ:INNV)

    InnovAge Holding Corp is a provider of senior services in the United States. The company has a market cap of 829.66M as of 2022 and a return on equity of -0.87%. The company offers a variety of services to seniors, including home health care, transportation, and meals. The company also has a number of programs designed to help seniors stay healthy and independent, such as exercise and wellness programs.

    – National Healthcare Corp ($NYSEAM:NHC)

    National Healthcare Corporation is a real estate investment trust that invests in senior housing and healthcare properties. As of December 31, 2020, the company owned and operated 245 senior housing and healthcare properties in 29 states and Puerto Rico.


    AVEANNA HEALTHCARE reported their Q2 2023 earnings on August 10 2023, showing that total revenue had increased by 6.5% year-over-year to USD 471.9 million, while net income was up by 105.4% to USD 25.6 million. This positive news led to the company’s stock price appreciating the same day, making it an attractive investing opportunity for those interested. Investors may want to consider the potential long-term upside of an investment in AVEANNA HEALTHCARE, taking into account their strong financial position and recent performance.

    Recent Posts

    Leave a Comment